A detailed history of Royce & Associates LP transactions in Avantor, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 51,772 shares of AVTR stock, worth $589,165. This represents 0.01% of its overall portfolio holdings.

Number of Shares
51,772
Previous 41,403 25.04%
Holding current value
$589,165
Previous $557,000 15.98%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$11.18 - $14.21 $115,925 - $147,343
10,369 Added 25.04%
51,772 $646,000
Q1 2025

May 06, 2025

BUY
$15.5 - $22.57 $641,746 - $934,465
41,403 New
41,403 $671,000

Others Institutions Holding AVTR

About Avantor, Inc.


  • Ticker AVTR
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 674,035,008
  • Market Cap $7.67B
  • Description
  • Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...
More about AVTR
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.